Meningococcal Vaccines Market - Forecast(2021 - 2026)
Meningococcal Vaccines Market size is expected to reach $4.2 billion by 2026, growing at a CAGR of 10.8% during the forecast period 2021-2026. Meningococcal vaccines are polysaccharide vaccines that are used to prevent diseases caused by meningococcus, which is a Gram-negative bacterium that can cause meningitis and other forms of meningococcal disease such as meningococcemia. The meningococcal disease results in infection of the lining of the brain and spinal cord and also has the potential to cause large epidemics. This disease is generally transmitted through direct contact with droplets of throat secretions from patients. Increase in the demand for combination vaccines and conjugate vaccines, growing government initiatives to replace the current meningitis vaccines with new vaccines to combat rising deaths, and rise in the adoption in developing countries in their national immunization programs are the factors that are set to drive the growth of the Me...